Ensembleui
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Ensemble is a unified agent and workflow orchestration platform that scales across various use cases, distinguishing itself from traditional RPA by handling dynamic, judgment-based orchestration that adapts to context. It is enterprise-ready with built-in security (SOC 2, ISO 27001, HIPAA, GDPR), compliance, observability, and evaluations, allowing users to focus on building experiences rather than maintaining AI infrastructure. Its proprietary agent harness ensures consistently reliable agent results.
Description Brand's website · 2026-10-04
Ensemble is a unified platform to build, embed, and manage AI agents and their configurations across various environments for businesses. It enables the creation of dynamic, judgment-based agent workflows, integrating with enterprise systems, and ensuring enterprise-grade security and compliance.
Offerings
Core capabilities Brand's website · 2026-10-04
- Ensemble Agent Experience Platform
- offering tools to build
- deploy
- and continuously improve AI agents and apps. Features include natural language workflow specification
- built-in knowledge management
- system integrations (JS
- SQL
- HTTP
- API)
- rich conversational interfaces
- AI-driven improvement based on user feedback
- and agent/workflow observability with native support for Evals
- Traceability
- Verification Agents
- and Human Feedback.
Pricing Brand's website · 2026-10-04
Not specified in the provided context.
Audience
Target industry Brand's website · 2026-10-04
Enterprises and businesses looking to serve people and teams at scale, requiring robust, scalable, and compliant AI agent solutions.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Ensembleui's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Ensembleui across the index.
Claim Ensembleui — free →Page last updated 2026-10-17.